[Risk-benefit considerations in the drug therapy of chronic tumor-related pain].
Cost and risk assessment in medicine requires evaluation of objective and subjective parameters. Objectively correct medicamentous treatment of chronic pain is cost-effective, above all by reducing expensive hospitalization. The greatest benefit for the patient comes from improved quality of life and increased independence and mobility. Side effects of drugs are inevitable but can be controlled successfully in most instances.